In addition to noted disease classes, three more heterogeneous AML categories were identified: AML presenting mutations of chromatin and RNA-splicing regulators, AML harboring TP53 mutations and/or chromosomal aneuploidies, and AML with IDH2R172 abnormalities. This evidence concerns the gene TP53 and acute myeloid leukemia.